Page 23 - GPD-2-2
P. 23
Gene & Protein in Disease MOR in cancer
92. Koodie L, Ramakrishnan S, Roy S, 2010, Morphine immune function via the JAK3/STAT5 pathway. Pain Res
suppresses tumor angiogenesis through a HIF-1alpha/ Manag, 2022: 9364365.
p38MAPK pathway. Am J Pathol, 177(2): 984–997.
https://doi.org/10.1155/2022/9364365
https://doi.org/10.2353/ajpath.2010.090621 105. Zielińska M, Szymaszkiewicz A, Jacenik D, et al., 2020,
93. Singleton PA, Mirzapoiazova T, Hasina R, et al., 2014, Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-
Increased µ-opioid receptor expression in metastatic lung D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and
cancer. Br J Anaesth, 113 Suppl 1: i103–i108. KOP opioid receptors, exerts anti-inflammatory and anti-
tumor activity in colitis and colitis-associated colorectal
https://doi.org/10.1093/bja/aeu165
cancer in mice. Eur J Pharmacol, 885: 173463.
94. Bimonte S, Barbieri A, Rea D, et al., 2015, Morphine
promotes tumor angiogenesis and increases breast cancer https://doi.org/10.1016/j.ejphar.2020.173463
progression. Biomed Res Int, 2015: 161508. 106. Boehncke S, Hardt K, Schadendorf D, et al., 2011,
Endogenous µ-opioid peptides modulate immune response
https://doi.org/10.1155/2015/161508
towards malignant melanoma. Exp Dermatol, 20(1): 24–28.
95. Murohara T, Asahara T, 2002, Nitric oxide and angiogenesis
in cardiovascular disease. Antioxid Redox Signal, 4(5): https://doi.org/10.1111/j.1600-0625.2010.01158.x
825–831. 107. Coluzzi F, Rullo L, Scerpa MS, et al., 2022, Current and
future therapeutic options in pain management: Multi-
https://doi.org/10.1089/152308602760598981
mechanistic opioids involving both MOR and NOP receptor
96. Dimmeler S, Zeiher AM, 2000, Endothelial cell apoptosis in activation. CNS Drugs, 36(6): 617–632.
angiogenesis and vessel regression. Circ Res, 87(6): 434–439.
https://doi.org/10.1007/s40263-022-00924-2
97. Hsiao PN, Chang MC, Cheng WF, et al., 2009, Morphine 108. Gorur A, Patiño M, Shi T, et al., 2021, Low doses of
induces apoptosis of human endothelial cells through nitric
oxide and reactive oxygen species pathways. Toxicology, methylnaltrexone inhibits head and neck squamous cell
256(1–2): 83–91. carcinoma growth in vitro and in vivo by acting on the
mu-opioid receptor. J Cell Physiol, 236(11): 7698–7710.
https://doi.org/10.1016/j.tox.2008.11.015
https://doi.org/10.1002/jcp.30421
98. Ziche M, Morbidelli L, 2000, Nitric oxide and angiogenesis. 109. Singleton PA, Moss J, 2010, Effect of perioperative opioids
J Neurooncol, 50(1–2): 139–148.
on cancer recurrence: A hypothesis. Future Oncol, 6(8):
https://doi.org/10.1023/a:1006431309841 1237–1242.
99. Kenny PA, Lee GY, Bissell MJ, Targeting the tumor https://doi.org/10.2217/fon.10.99
microenvironment. Front Biosci, 12: 3468–3474.
110. da Silva JL, Dos Santos AL, Nunes NC, de Moraes Lino
https://doi.org/10.2741/2327 da Silva F, et al., 2019, Cancer immunotherapy: The art of
100. Sung SY, Hsieh CL, Wu D, et al., 2007, Tumor targeting the tumor immune microenvironment. Cancer
microenvironment promotes cancer progression, metastasis, Chemother Pharmacol, 84(4): 227–240.
and therapeutic resistance. Curr Probl Cancer, 31(2): 36–100. https://doi.org/10.1007/s00280-019-03894-3
https://doi.org10.1016/j.currproblcancer.2006.12.002 111. Esfahani K, Roudaia L, Buhlaiga N, et al., 2020, A review of
cancer immunotherapy: From the past, to the present, to the
101. Fang H, Declerck YA, 2013, Targeting the tumor
microenvironment: From understanding pathways to future. Curr Oncol, 27: S87–S97.
effective clinical trials. Cancer Res, 73(16): 4965–4977. https://doi.org/10.3747/co.27.5223
https://doi.org/10.1158/0008-5472.CAN-13-0661 112. Emens LA, 2018, Breast cancer immunotherapy: Facts and
hopes. Clin Cancer Res, 24(3): 511–520.
102. Liang X, Liu R, Chen C, et al., 2016, Opioid system modulates
the immune function: A review. Transl Perioper Pain Med, https://doi.org/10.1158/1078-0432.CCR-16-3001
1(1): 5–13.
113. Chen G, Kim YH, Li H, et al., 2017, PD-L1 inhibits acute
103. Koodie L, Yuan H, Pumper JA, et al., 2014, Morphine and chronic pain by suppressing nociceptive neuron activity
inhibits migration of tumor-infiltrating leukocytes and via PD-1. Nat Neurosci, 20(7): 917–926.
suppresses angiogenesis associated with tumor growth in https://doi.org/10.1038/nn.4571
mice. Am J Pathol, 184(4): 1073–1084.
114. McLaughlin PJ, Verderame MF, Hankins JL, et al., 2007,
https://doi.org/10.1016/j.ajpath.2013.12.019
Overexpression of the opioid growth factor receptor
104. Jiang Y, Li T, Qian Y, et al., 2022, Morphine in combination downregulates cell proliferation of human squamous
with ketamine improves cervical cancer pain and suppresses carcinoma cells of the head and neck. Int J Mol Med, 19(3):
Volume 2 Issue 2 (2023) 17 https://doi.org/10.36922/gpd.282

